1 / 19

SHAIPI and SIRN Collaborative Infection Research

SHAIPI and SIRN Collaborative Infection Research. Background. HAI costs £183M annually Occurs in 5% of the acute hospital population Major policy area for Scottish Government Changing epidemiology of organisms ( E coli/S aures ) AMR is now a recognised threat

pennyt
Download Presentation

SHAIPI and SIRN Collaborative Infection Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SHAIPI and SIRN Collaborative Infection Research

  2. Background • HAI costs £183M annually • Occurs in 5% of the acute hospital population • Major policy area for Scottish Government • Changing epidemiology of organisms (E coli/S aures) • AMR is now a recognised threat • A lot of practice in HAI control has little or no evidence base

  3. Scottish Infection Research Network • Formed in 2006 at the request of the Scottish Government • Supported 33 projects: £1k- £4.3M. Total £6M. • Secretariat based in Glasgow University • Scottish Government secretariat funding for 17-18.

  4. SIRN Remit Build a sustainable, high quality research infrastructure Build capacity within the HAI research community Develop and support effective collaborative relationships Develop and shape high quality research bids Initiate a research stream to evaluate current HAI practice Endorse and promote HAI related research that is scientifically credible and has practical application Generate, apply and disseminate HAI knowledge that enhances delivery and quality of patient care

  5. Consortium A National consortium over 5 years Developing and utilising 3 National strengths Based on 9 key priority areas identified by SGHD Translational Self sustaining

  6. Biosciences Informatics • Behavioural science (Practice based interventions) • Scottish HAI Prevention Institute (SHAIPI)

  7. Scottish Healthcare Associated Infection Prevention Institute (SHAIPI)Strategic vision To become a recognised Institute for excellence in HAI Research utilising • Rapid knowledge transfer • State of the art laboratory techniques • Informatics • Novel interventions and developing evidence for existing interventions To tackle the threat to public health from emergent HAI and antimicrobial resistance in a co-ordinated fashion

  8. SHAIPI 19 CoIs, 5 HEIs ( Glasgow University (genomics, informatics); Glasgow Caledonian University (applied infection prevention, patient experience); Strathclyde University (clinical informatics, statistics), Dundee University (informatics, pharmacology), St Andrews University (genomics,informatics) 3 HBs Grampian, Tayside, Fife Strategic partners working with this consortium include: • PHI: epidemiology and access to European network of 28 countries • Farr institute: access to UK health informatics research network, health policy advice • IPS: Infection control practitioners and potential for CARC capacity building in Scotland through internships and international partnerships through the Society • HENs (Health economics network): developing health economic analysis of interventions • SMVN (Scottish Microbiology and Virology Network): microbiology samples, isolates and laboratory data • SICSAG (Scottish Intensive Care Society Audit group) and Scottish Critical Care Trials Group: provide a network to develop a National clinical dataset, identify and trial interventions. • Scottish Reference laboratories: organism specific expertise, national collections and datasets • SAPG (Scottish Antimicrobial Prescribing Group): focussed on optimising prescribing practice and reducing antimicrobial resistance. • Sanger Centre

  9. Interconnections of Workstreams Feedback loop for WS1,2&3

  10. Years 1 and 2: Laying the Foundations • Develop an understanding of the epidemiology of the key organisms causing HAI in Scotland.

  11. Years 1 and 2: Laying the Foundations • Phase 1 risk modelling using existing IIP national data providing initial risk estimates for being a case and risk modelling for the outcome of cases for: • C.difficile, • S.aureus • E.coli • VRE

  12. Mortality and discharge status using National datasets • After adjustment the hazard ratio (HR) of death for Cases relative to Controls • HR 2.12 (95% CI 1.93, 2.33)

  13. Importance of IPC • Little evidence existed on the components required for effective national IPC interventions • The previous WHO guidance on national IPC components was based on expert opinion • WHO recently commissioned this systematic review

  14. Search Results Additional records identified through other sources (n = 139) Records identified through database searching (n = 9,960) Identification Records after duplicates removed (n = 9,777) Screening Records screened (n = 9,777) Records excluded (n = 9,422) Full-text articles assessed for inclusion criteria (n = 355) Full-text articles excluded, with reasons (n = 326) Not primary research studies, no intervention, not national implementation, not HAI, not CRT, NRT, ITS, CBA studies Eligibility Included Studies included (n = 29 reported in 30 articles)

  15. Summary WHY? • To inform development of international guidance on national IPC programmes • Systematic review – the first to evaluate IPC interventions at the national level • Multimodal interventions were supported by the highest number of studies and showed the most impactful results • Good quality evidence was limited to a small number of studies • Best available evidence to inform international recommendations comes from individual studies on IPC multimodal interventions and a study on surveillance, monitoring and feedback HOW? WHAT?

  16. Years 3 to 5: Patient centred outputs • Provide a responsive typing facility that can be used for outbreak control • Targeted interventions on the epidemiology of causative HAI organisms • Phase 2 risk modelling of HAI focussing on E.coli / S.aureus outcomes • Integration of risk models in service delivery

  17. SHAIPI Wider Deliverables • Strengthen HAI translational applied research capacity within Scotland via development of researchers at various career stages • 6 additional PhD studentships • Improved capacity to capture externally funded research grants • £2.13M additional funding • Collaborations • HPS developed Scottish AMR Research Consortium (SARC) • Produce REF 2020 returnable research outputs of 3 and 4 star • 21 papers • 21 conference presentations • Translate research into learning opportunities for under-and postgraduate students and NHS practitioners • Regular SHAIPI research events including annual International Advisory Droup meeting • European and international collaboration in research • WHO Evidence for IPC work

  18. Pie in the Sky? • Patient with UTI • CHI identification SMR1 ECOSS Data linkage Analytic platform Risk modelling Validated models nRTS High resolution typing AMR genotyping • E. coli Targeted IPC Interventions Targeted prevention and Management SICPs/TBPs evidence for generic Interventions Evaluation of Patient and practitioner Experience

  19. FINwww.glasgow.ac.uk/sirn

More Related